These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11134740)

  • 41. Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR).
    Wilczek HE; Larsson M; Ericzon BG;
    Amyloid; 2011 Jun; 18 Suppl 1():193-5. PubMed ID: 21838484
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy.
    Suhr O; Danielsson A; Rydh A; Nyhlin N; Hietala SO; Steen L
    Dig Dis Sci; 1996 Oct; 41(10):1909-14. PubMed ID: 8888700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation.
    Ramsay MA
    Liver Transpl Surg; 1997 Nov; 3(6):665-8. PubMed ID: 9404974
    [No Abstract]   [Full Text] [Related]  

  • 44. Domino liver transplantation as a cause of acquired familial amyloid polyneuropathy.
    Abdelfatah MM; Hayman SR; Gertz MA
    Amyloid; 2014 Jun; 21(2):136-7. PubMed ID: 24517476
    [No Abstract]   [Full Text] [Related]  

  • 45. Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival.
    Suhr OB; Ando Y; Holmgren G; Wikström L; Friman S; Herlenius G; Ericzon BG
    Transpl Int; 1998; 11 Suppl 1():S160-3. PubMed ID: 9664969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Posttransplant cerebral hemorrhage in a patient with familial amyloidotic polyneuropathy.
    Rinaldi L; Busani S; Pasetto A; Girardis M
    Transplantation; 2006 Jan; 81(1):134-5. PubMed ID: 16421491
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiac evaluation of patients with familial amyloidotic polyneuropathy proposed for liver transplantation.
    Acosta F; De La Morena G; Villegas M; Sansano T; Reche M; Beltran R; Roques V; Contreras RF; Robles R; Bueno FS; Ramirez P; Parrilla P
    Transplant Proc; 1999 Sep; 31(6):2372. PubMed ID: 10500624
    [No Abstract]   [Full Text] [Related]  

  • 48. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy.
    Lång K; Wikström L; Danielsson A; Tashima K; Suhr OB
    Scand J Gastroenterol; 2000 Sep; 35(9):985-9. PubMed ID: 11063162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy.
    Parrilla P; Ramirez P; Bueno FS; Robles R; Acosta F; Miras M; Pons JA; Andreu FL; Munar-Ques M
    Br J Surg; 1995 Jun; 82(6):825-8. PubMed ID: 7627523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life.
    Jonsén E; Suhr OB; Tashima K; Athlin E
    Amyloid; 2001 Mar; 8(1):52-7. PubMed ID: 11293825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy.
    Anan I; El-Salhy M; Nyhlin N; Suhr OB
    Transplantation; 2000 Sep; 70(5):794-9. PubMed ID: 11003360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral nerves regenerated in familial amyloid polyneuropathy after liver transplantation.
    Ikeda S; Takei Y; Yanagisawa N; Matsunami H; Hashikura Y; Ikegami T; Kawasaki S
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):618-20. PubMed ID: 9341060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients.
    Takei Y; Ikeda S; Hashikura Y; Ikegami T; Kawasaki S
    Ann Intern Med; 1999 Oct; 131(8):592-5. PubMed ID: 10523220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy.
    Suhr OB; Wiklund U; Eleborg L; Ando Y; Backman C; Birgersdotter V; Bjerle P; Ericzon BG; Johansson B; Olofsson BO
    Transplantation; 1997 Mar; 63(5):675-9. PubMed ID: 9075837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperfibrinolysis.
    Hunt BJ; Segal H
    J Clin Pathol; 1996 Dec; 49(12):958. PubMed ID: 9038728
    [No Abstract]   [Full Text] [Related]  

  • 56. De novo hereditary (familial) amyloid polyneuropathy (FAP) in a FAP liver recipient.
    Guttmann S; Röcken C; Schmidt M; Grünewald I; Zibert A; Stypmann J; Schilling M; Schmidt H
    Amyloid; 2017 Mar; 24(sup1):126-127. PubMed ID: 28434329
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 58. Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserum.
    Kishikawa M; Nakanishi T; Miyazaki A; Shimizu A; Nakazato M; Kangawa K; Matsuo H
    J Mass Spectrom; 1996 Jan; 31(1):112-4. PubMed ID: 8799265
    [No Abstract]   [Full Text] [Related]  

  • 59. Domino liver transplantation for familial amyloid polyneuropathy: optimal use of a scarce resource.
    Hemming AW; Cattral MS; Greig PD; Lilly LB; Ashby P; Levy GA
    Transplant Proc; 1999; 31(1-2):515. PubMed ID: 10083215
    [No Abstract]   [Full Text] [Related]  

  • 60. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography.
    De Souza RL; Short T; Warman GR; Maclennan N; Young Y
    Anaesth Intensive Care; 2004 Aug; 32(4):580-7. PubMed ID: 15675222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.